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Abstract
Introduction: Health laboratory services are a critical component of national health systems but face major operational challenges in resource-li-
mited (RL) settings. New funding for health systems strengthening in RL countries has increased the demand for diagnostics and provided opportu-
nities to address these constraints. An approach to sustainably strengthen national laboratory systems in sub-Saharan African countries is the Stren-
gthening Laboratory Management Toward Accreditation (SLMTA) programme. External Quality Assessment (EQA) is a requirement for laboratory 
accreditation. EQA comprises proficiency testing (PT), rechecking of samples and on-site evaluation.
Materials and methods: A systematic literature search was conducted to identify studies addressing laboratory EQA and quality monitoring in RL 
countries. Unpublished reports were also sought from national laboratory authorities and personnel.
Results: PT schemes in RL countries are provided by commercial companies, institutions in developed countries and national programmes. Most 
government-supported PT schemes address single diseases using a vertical approach. Regional approaches to delivering PT have also been imple-
mented across RL countries. Rechecking schemes address mainly tuberculosis (TB), malaria and human immunodeficiency virus (HIV); integrated 
rechecking programmes have been piloted. Constraints include sample transportation, communication of results, unknown proficiency of referee 
staff and limited resources for corrective action. Global competency assessment standards for malaria microscopists have been established.
Conclusions: EQA is vital for monitoring laboratory performance and maintaining quality of laboratory services, and is a valuable tool for iden-
tifying and assessing technology in use, identifying gaps in laboratory performance and targeting training needs. Accreditation of PT providers and 
competency of EQA personnel must be ensured.
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Introduction
Medical and public health laboratory services are 
a critical component of national health systems 
and are central to disease diagnosis, treatment, 
prevention, surveillance and outbreak investiga-
tions (1). When used optimally, laboratory medicine 
generates knowledge that facilitates patient safety, 
improves patient outcomes and leads to more 
cost-effective healthcare (2). In the United States of 
America, laboratory testing influences 60–70% of 
critical decision-making in health, with community 
laboratories performing at least 50% of all testing 
(3). In the primary healthcare setting in resource-
limited (RL) countries, laboratory testing may influ-
ence 45% of medical decision-making (4). 
Until recently, allocation of resources to laboratory 
testing was of low priority for healthcare systems 
in many sub-Saharan African (SSA) countries. Unre-
liable and inaccurate laboratory diagnostic testing 
has promoted the perception that laboratory test-
ing is unhelpful and may compromise patient care 
(5). Major challenges facing laboratory services in 
under-developed settings include weak infrastruc-
ture, human capacity shortages, and lack of labo-
ratory policies, strategic plans and integrated na-
tional quality management systems (6,7). Funding 
opportunities for health systems strengthening in 
RL countries such as the Global Health Initiative, 
US President’s Emergency Plan for AIDS Relief, and 
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Global Fund to Fight AIDS, Tuberculosis and Malar-
ia have increased demand for diagnostics and pro-
vided opportunities to address this neglect and 
strengthen capacity of public health laboratory 
networks (8).
Microscopy remains an important laboratory diag-
nostic procedure in RL countries and provides the 
basis for managing and controlling several bacte-
rial and parasitic infections, including tuberculosis 
(TB) and malaria. Absent or poor malaria microsco-
py has long been recognised and is attributed to 
multiple factors, including skills of the laboratory 
workforce, workload, condition of microscopes 
and quality of laboratory supplies (9). Reyburn et 
al. found only 46.1% of 4474 patients treated for 
severe malaria in 10 hospitals in Tanzania had posi-
tive blood films (10); Zurovac et al. showed 68.6% 
sensitivity and 61.5% specificity of malaria micros-
copy in outpatients attending 17 government 
health facilities in two districts in Kenya (11); Kaha-
ma-Moro et al. found 71.4% sensitivity and 47.3% 
specificity of routine blood slides in 12 urban pub-
lic health facilities in Dar es Salaam, Tanzania (12). 
Misclassification of malaria species occurs from 
lack of skills in microscopic diagnosis (13). Improv-
ing and monitoring malaria-related test perfor-
mance in peripheral laboratories on a countrywide 
basis is achieved through training and supervision 
but programmes must be sustained by national 
commitment (14). However, focusing on improv-
ing diagnosis for one disease may lead to over-di-
agnosis of another illness (15). Perceptions and at-
titudes of healthcare providers on quality of labo-
ratory services also affect their correct use for pa-
tient management (16).
Malaria rapid diagnostic tests (RDT) were intro-
duced to address challenges of poor malaria mi-
croscopy and promote greater accessibility to ma-
laria confirmation, but errors in performing RDT are 
widespread (17,18). Community health workers can 
use RDT safely and accurately for up to 12 months 
post-training (19). Standardised product perfor-
mance evaluations that distinguish between well 
and poorly performing tests are also essential (20). 
An innovative approach to sustainably strengthen 
national laboratory systems in RL countries in Afri-
ca is the World Health Organization Regional Of-
fice for Africa (WHO AFRO) Stepwise Laboratory 
Quality Improvement Process Towards Accredita-
tion (SLIPTA) framework linked to the Strengthen-
ing Laboratory Management Toward Accreditation 
(SLMTA) training programme. SLMTA was intro-
duced in 2009 to provide a systematic, user-friend-
ly approach to achieving laboratory quality im-
provement and accreditation (21) and uses a com-
petency-based, step-wise process addressing daily 
laboratory operations for immediate and measura-
ble laboratory improvement, harmonised to Inter-
national Organization for Standardization (ISO) 
15189 standards (8). Accreditation is the interna-
tionally accepted framework for verifying that lab-
oratories adhere to established quality and compe-
tence standards for accurate and reliable patient 
testing. In some countries, laboratory accreditation 
is mandatory; in others, accreditation remains vol-
untary and may be driven by market incentives (22).
The World Health Organization (WHO) defines Ex-
ternal Quality Assessment (EQA) as a system for 
objectively checking a laboratory’s performance 
using an external agency or facility (23). EQA par-
ticipation is associated with improved laboratory 
performance over time and is a requirement for 
accreditation (24). However, many professionals in 
SSA countries are unable to effectively implement 
quality improvement programmes and many 
countries remain without an accredited clinical 
laboratory (25). Establishing, maintaining and 
demonstrating the accuracy of diagnostic tests is a 
major challenge for most laboratories in SSA, and 
the complexity and cost of setting up and main-
taining quality assurance systems mean that very 
few laboratories, mainly tertiary or privately 
owned, can achieve these standards (26,27). The 
common perception that EQA is costly or unneces-
sary has hindered the widespread enrolment of 
laboratories into EQA programmes (28).
EQA can be applied in three main ways, each with 
advantages and disadvantages: 1) Proficiency test-
ing (PT), where an external provider sends sam-
ples of undisclosed results to laboratories or indi-
vidual testers and provides feedback on results; 2) 
Rechecking or retesting samples in higher level or 
peer laboratories (inter-laboratory comparison); 3) 
On-site assessment by approved evaluators (23).
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Materials and methods
A systematic search of published literature was 
conducted to identify studies addressing quality 
monitoring and laboratory performance in RL 
countries. RL countries were selected as countries 
with low and lower middle-income economies 
(29). Unpublished reports were sought from na-




Several laboratories in RL countries are enrolled in 
international or regional PT schemes operated by 
commercial companies. These offer a wide range 
of discipline-specific schemes suitable mainly for 
reference or larger laboratories. Advantages in-
clude a high level of participation with different 
analytical methods, thereby increasing statistical 
validity. However, government laboratories in RL 
countries, unless partner supported, may be una-
ble to sustain participation due to high cost. Some 
institutions in developed countries operate PT 
schemes that also support RL countries at cost. 
These include the United Kingdom National EQA 
Scheme (UK NEQAS) that provides a wide range of 
PT schemes and educational support; and the Afri-
can Regional External Quality Assessment Scheme 
implemented by the National Health Laboratory 
Service (NHLS), South Africa, that offers a range of 
PT materials including stable inactivated myco-
bacterial dried culture spot (DCS) material for Gen-
eXpert instruments performing the Xpert MTB/RIF 
assay (Cepheid, Sunnyvale, CA) (30). 
Table 1 summarises evaluations of PT schemes in 
developed countries supporting RL countries. The 
National Institute for Communicable Diseases 
(NICD), South Africa, has provided PT support to 
national public health laboratories and related fa-
cilities in RL countries in the WHO AFRO and East-
ern Mediterranean regions since 2002, supported 
by WHO AFRO and the WHO Office in Lyon, France. 
Levels of participation and performance were sub-








increased to 78 in 48 
WHO member states
Bacteriological analyses for 
enteric diseases, meningitis and 
plague; unstained blood films for 
Y. pestis; stained and unstained TB 
smears; thick and thin blood films 
for malaria
3 surveys per year
Each survey returned by 64–93% participants.
Bacterial identification for enteric diseases and 
meningitis acceptable in 65% and 69% challenges.
Serotyping and antibiotic susceptibility testing 
frequently unacceptable.
Microscopy acceptable for 73%, 87% and 82% 
plague, TB and malaria challenges
51% malaria parasite quantitation scores acceptable.
QASI, Canada 
(32)
115 laboratories in 
47 developed and RL 
countries
5 consecutive shipments 
of stabilised blood for CD4 
enumeration
Survey responses from 23–92 laboratories.
Coefficient of variation for CD4% decreased from 
7.2% to 4.7%; absolute CD4 counts from 14.2% to 8.8%.
NHLS, South 
Africa (33)
13–195 sites in South 
Africa and other SSA 
countries
20 trials of stabilised blood for 
CD4 enumeration
Response rate 86–100%.
Inter-laboratory precision 10.8% for CD4% counts 





10 laboratories in 
8 SAARC member 
states
7 rounds with total 778 TB slides
87.5% to 100% inter-laboratory agreement.
14 minor errors; 1 major error.
Sensitivity 90.9–100%. Specificity 83.33–100%.
NICD – National Institute for Communicable Diseases; WHO – World Health Organization; TB – tuberculosis; QASI - Quality 
Assessment and Standardization for Immunological Measures Relevant to HIV/AIDS; RL – resource limited; CD4 - cluster of 
differentiation 4; NHLS – National Health Laboratory Service; SAARC – South Asian Association for Regional Cooperation.
Table 1. Proficiency testing schemes in developed countries supporting RL countries
Biochemia Medica 2017;27(1):97–109  http://doi.org/10.11613/BM.2017.013 
100
Carter JY. EQA in resource-limited countries
over time across all diseases despite several 
scheme-associated training visits provided by 
NICD and WHO AFRO (31). The Quality Assessment 
and Standardization for Immunological Measures 
Relevant to HIV/AIDS (QASI), Canada, was estab-
lished in 1997 to provide PT for CD4 enumeration 
at no or low cost to RL laboratories. An impact 
study demonstrated PT programmes can improve 
overall laboratory performance despite the diver-
sity of technologies employed (32). An impact 
study of CD4 EQA provided by the NHLS, South Af-
rica, from 2002 to 2006 demonstrated how EQA 
provides an opportunity for post-market surveil-
lance, standardising protocols and switching oper-
ating systems (33). A regional PT programme for 
TB smear microscopy conducted between 2003 
and 2010 across South Asian Association for Re-
gional Cooperation (SAARC) member states dem-
onstrated the on-going quality of diagnostic sup-
port to countries’ TB control programmes (34). The 
East African Regional External Quality Assessment 
Scheme (EA-REQAS) established in 2008 by the 
East African ministries of health provides integrat-
ed PT panels for basic laboratory tests. By 2015, 16 
surveys had been conducted with enrolment in-
creasing from 195 to 559 laboratories in four coun-
tries. Materials include blood slides for malaria and 
other blood parasites, smears for TB and Gram stain, 
preserved stool parasites, blood lysate for haemo-
globin measurement, blood films for peripheral 
blood cell morphology, and human immuno-
deficiency virus (HIV) and syphilis serology (35). 
Many RL countries operate national disease-specif-
ic PT programmes. Mukadi et al. described four 
studies in the Democratic Republic of Congo (DRC) 
between 2010 and 2014; three involved submis-
sion of single panels of blood slides for microsco-
py to 183, 356 and 445 laboratories respectively 
(36-38). Panel composition and results are present-
ed in Table 2. In the second study, there was a low-
Participating / responding 
laboratories (% response) Materials Results
183 / 174
(95.1%)*
Three thick and thin Giemsa-stained blood 
films:
- P. falciparum (177,000/μL)
- P. falciparum (86/μL)
- Parasite negative
34.3%, 21.5% and 5.8% errors in 1, 2 & 3 slides.
Thin blood film, negative parasites, Howell 
Jolly bodies




Four thick and thin Giemsa-stained blood 
films:
- P. falciparum gametocytes
- Parasite negative
- Trypanosoma brucei spp.
- P. falciparum (113,530/μL)
 
 
35.0% reported four slides correctly.
17.5% non-recognition of P. falciparum gametocytes.
19.0% reported parasites in negative slide.
50.4% non-recognition of trypanosomes.
445 / 400
(89.9%)‡




- P. falciparum (09 ± 107/μL) and Trypanosoma 
(1–3/microscopic field)
- Trypanosoma (0–1/4 microscopic fields)
- P. ovale (1,938 ± 326/μL)
 
30.6% reported malaria
11.0% reported P. malariae correctly.
32.5%/16.5% reported P. falciparum/Trypanosoma; 
6.0% reported both.
44.9% reported Trypanosoma.
6.2% reported P. ovale; 68.8% reported malaria.
1892 / 1849 (97.7%) health 
workers§ 10 photographs of malaria RDT results
18.5% correct scores (10 / 10)
24.1% correct scores of 9 – 9.5
22.2% scores < 6.5
Source: *(36), †(37), ‡(38), §(17); RDT – rapid diagnostic test.
Table 2. Blood slide proficiency testing studies in Democratic Republic of Congo  
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er frequency of serious errors in assessing parasite 
density (17.2% vs. 52.3%, P < 0.001) and reporting 
false-positive results (19.0% vs. 33.3%, P < 0.001) by 
laboratories that had participated in the first study; 
laboratories with a high number of sleeping sick-
ness cases recognised trypanosomes more fre-
quently (57.0% vs. 31.2%, P < 0.001). In the third 
study the proportion of correct or acceptable 
scores was higher among EQA-experienced par-
ticipants compared to first time participants 
(40.9% vs. 22.4%, P = 0.001), and higher among 
those trained < 2 years previously compared to 
those not trained (42.9% vs. 26.3%, P = 0.01). The 
fourth study analysed interpretation of photo-
graphs of RDT results by laboratory workers; the 
most frequent errors were failure to recognise in-
valid or negative test results, overlooking faint test 
lines and incorrectly identifying malaria parasite 
species (17). 
Rechecking and mixed EQA schemes 
Many RL countries operate slide-rechecking 
schemes as part of national malaria, TB and HIV 
control programmes. Malaria and TB slide recheck-
ing is performed by supervisors on-site, at next 
level health facilities or central reference laborato-
ries; rechecking of HIV RDT results is usually per-
formed at central level. Since the blanket approach 
of rechecking 100% positive and 10% negative ac-
id-fast bacilli (AFB) slides was withdrawn (39), most 
studies reported using standard LQAS (lot quality 
assurance sampling) based on annual laboratory 
volume of AFB smears and proportion of positive 
smears to achieve an overall sensitivity of 75–85%, 
and processes for blinded rechecking. A signifi-
cantly greater percentage of errors is detected on 
randomly selected, blinded AFB smears than on 
non-randomly selected, un-blinded smears; 
knowledge of prior results influences re-reading of 
TB slides (40-42). 
Table 3 summarises studies assessing laboratory 
performance through rechecking of AFB smears, 
malaria slides and HIV RDT results; some studies 
used mixed EQA methods. Malik et al. reported 
random blinded slide rechecking of AFB smears is 
feasible for a large application with 40,506 slides 
rechecked over a two-year period at 24 sites in 
New Delhi, India (43). Selvakumar et al. reported 
rechecking of 8 slides per month per microscopy 
centre was sufficient to assess performance of spu-
tum smear microscopy in 12 centres in one district 
in India, based on sensitivity of 80%, specificity of 
100%, slide positivity rate of 10% and annual neg-
ative smear volume of 1000–5000 slides. (44). They 
also noted the discrepancy between microscopy 
centres and district supervisors was higher (4.7%) 
than with the reference laboratory (1%), suggest-
ing lack of training and motivation at district level 
(45). Shiferaw et al. noted false negative results 
during rechecking were associated with unavaila-
bility of microscope lens cleaning solution and 
dirty smears, and false positive results with no pre-
vious EQA experience (46). Shargie et al. suggested 
disagreements during rechecking between re-
gional and national reference readers are likely 
due to low-positivity of discordant slides (47). 
Mundy et al. established excellent concordance 
(98.2%) on rechecking TB smears after instituting 
basic internal quality control in one district in Ma-
lawi (48). Manalebh et al. studied three EQA meth-
ods to assess AFB smear microscopy performance 
in Ethiopia: on-site evaluation, blinded rechecking 
and panel testing; poor staining and low positivity 
were major factors affecting PT performance (49). 
Ayana et al. employed similar mixed approaches to 
assess AFB smear microscopy at university practi-
cal attachment sites in Ethiopia; poor working en-
vironments were a major contributor to poor per-
formance (50). Some studies noted re-staining 
during rechecking at national level significantly 
improved sensitivity of low-positive AFB smears 
(41,51). 
Random monthly selection of five low density and 
five negative malaria slides has been proposed for 
routine rechecking (52). A study from Rwanda re-
ported excellent quality of malaria slide re-reading 
without grading of positive slides (53). Khan et al. 
studied malaria slide reading performance in Paki-
stan after instituting three activities: on-site re-
checking of malaria slides, uninterrupted availabil-
ity of laboratory reagents and supplies, and super-
vision by district supervisors (54); Wafula et al. in-
stituted four concurrent activities in Kenya: re-
reading of malaria films; feedback on quality of 
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India (41) 41,978 TB slides from 12 microscopy centres rechecked by supervisors and national level
False negatives 2–7% by centres; 0–3% by supervisors; 
re-staining and blinded rereading reduced false positives 
from 27% to 7%
India (43) 40,506 TB slides from 183 microscopy centres rechecked by district supervisors 446 errors (2.2%)
India (44,45)
1547 TB slides from 7 microscopy centres 
rechecked by district supervisors; 726 TB slides 
from 5 microscopy centres rechecked at reference 
level
70 errors by district supervisors; 2 errors by reference 
laboratory reader
Ethiopia (46) 39,725 TB slides from 201 laboratories rechecked at 26 EQA centres
68 false positives in 41 (20.4%) laboratories;
67 false negatives in 29 (14.4%) laboratories
Ethiopia (47) 2209 TB slides rechecked at regional level; discordant slides rechecked at national level
96.8% overall agreement; 3.2% false positives; 74% 
agreement between regional and national readers on 95 
discordant slides
Malawi (48) 208 TB smears from 1 hospital/32 health centres rechecked at district hospital
Concordance 98.1% for positive smears; 98.2% for negative 
smears
Ethiopia (49)
37 public-private mix laboratories:
1123 TB smears rechecked at regional laboratory
PT of 370 TB panel smears
99.4% agreement
Overall agreement 96%; errors reading unstained and 
ready-stained smears 62% vs. 38%
Ethiopia (50)
8 health institution laboratories:
578 TB smears rechecked at university laboratory
PT of 10 TB panel smears
94.5% agreement; 3 (3.75%) major errors (high false positives)
Overall error 17 (25.25%); 14 (17.5 %) minor errors; 3 (3.75%) 
major errors (high false positives)
Burundi (51) 1014 TB slides from 72 microscopy centres rechecked at reference level
31.2%/6.9% false positives; 1.2%/4.1% false negatives before/
after re-staining.
Rwanda (53) 20 positive, 20 negative malaria slides from 3 laboratories rechecked at reference level 96.67% agreement
Pakistan (54) On-site rechecking of 1170 malaria slides in 4 districts by district supervisors 0.5–1% discordance
Kenya (55) 4514 malaria slides rechecked from 17 health centres by study microscopist Average sensitivity 96%, specificity 88%
Nigeria (56) TB slides from 5 centres; malaria slides from 2 centres rechecked at state level
From baseline to final assessment:
Concordance for TB microscopy increased from 81% to 91.0%
Concordance for malaria microscopy increased from 69.2% 
to 83.3% at 1 laboratory; decreased from 100% to 83.3% in 
second laboratory.
Nepal (57) DBS from 5 centres retested using repeat HIV RDT and ELISA at national level
RDT results 100% concordant
ELISA: 32 samples (91.4%) concordant; 3 samples (8.6%) 
discordant; sensitivity 88.9%; specificity 94.0%
Ethiopia (58)
64 TB slides, 64 malaria slides, 64 HIV blood 
samples from 4 health centres rechecked at 
district level
Agreement of 98.4% (63/64), 92.2% (59/64) and 95.3% (61/64) 
for TB microscopy, malaria microscopy and HIV rapid testing
TB – tuberculosis; EQA – external quality assessment; PT – proficiency testing; DBS – dried blood spots; RDT – rapid diagnostic test; 
ELISA – enzyme-linked immunosorbent assay.
Table 3. Summary of rechecking and mixed EQA studies
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slide preparation; preparation of monthly labora-
tory performance reports; and on-the-job mentor-
ship (55). These studies demonstrated the benefi-
cial effects of additional support on performance. 
Sarkinfada et al. described systematic integration 
of malaria slide rechecking within an existing TB 
microscopy-rechecking scheme in Nigeria. Similar 
systems were adopted for recording results, slide 
sampling and storage, feedback mechanisms and 
monitoring visits to laboratories. Use of the same 
microscopists and microscopes, and joint training 
and supervision were feasible at laboratory level 
but successfully integrating these schemes re-
quires combined TB and malaria management 
support at national level (56). Thapa et al. used 
dried blood spots (DBS) for repeat HIV RDT and 
enzyme-linked immunosorbent assay (ELISA) test-
ing at reference level in Nepal and demonstrated 
superior sensitivity and specificity of ELISA testing 
(57). Manyazewal et al. integrated TB and malaria 
slide rechecking with HIV retesting in Ethiopia and 
emphasised the role secondary laboratories can 
play in assuring laboratory quality at primary level 
to avoid dependence on remotely located nation-
al and regional laboratories (58). 
Competency assessment of slide readers
Vieira et al. proposed double-blind sputum smear 
microscopy readings using a panel of 75 slides (36 
negative, 4 inconclusive, 35 positive) to assess pro-
ficiency of readers and supervisors in TB smear mi-
croscopy (59). Dave et al. assessed technical perfor-
mance of laboratory supervisors using testing 
panels comprising 5 heat-fixed unstained sputum 
slides (including TB positives of any grade and 
negatives) for staining and examination; only 5% 
of 295 readers reported any type of error (60). 
Ayalew et al. provided 80 laboratory professionals 
from public and private health facilities in Ethiopia 
with 10 panel slides containing P. falciparum, P. 
vivax, mixed species and negative slides. Overall 
agreement in malaria parasite detection and spe-
cies identification was 88% and 74.3% respective-
ly; agreement was lower in slides with low parasite 
density and mixed infection (61). A multi-country 
network to address competency of malaria mi-
croscopists was established in Asia in 2003 with 
five-day courses to assess competency in parasite 
detection, species identification and parasite 
quantitation conducted by an external facilitator 
using reference slide panels from the Research In-
stitute for Tropical Medicine, Manila, Philippines, 
regional slide bank. By 2011, 60 competency as-
sessment exercises had been conducted in 14 
countries; microscopists from 5 countries showed 
significant improvements in performance scores 
(62). This programme has translated into globally 
recognised standards of competency in malaria 
microscopy (52).
Benefits
EQA schemes are valuable for recognising labora-
tory errors and identifying underlying problems 
facing peripheral laboratories (50), but participa-
tion in PT schemes may not by themselves im-
prove performance. Mandy et al. and Mukadi et al. 
noted improved performance after several rounds 
of participation in PT (32,37); however, Paramasi-
van et al. noted no significant improvement after 
submitting five rounds of TB panels, even after 
communicating observed deficiencies to partici-
pants (63). Frean et al. noted little improvement in 
performance over time in the NICD-supported PT 
programme (31). Van Rie et al. evaluated the ef-
fects of 5-day refresher training for laboratory 
technicians and distribution of new microscopes 
on the quality of TB smear microscopy in 13 prima-
ry healthcare laboratories in Kinshasa, DRC, 
through blinded rechecking of slides, but no long-
term effect was demonstrated with major errors 
occurring in 10 (77%) clinics after 9 months (64).
Challenges
Despite the widespread use of malaria RDT in RL 
countries, tools available for monitoring field per-
formance are limited. Masanja et al. compared RDT 
performance with malaria reference microscopy 
and detection of parasite DNA by real-time quanti-
tative polymerase chain reaction (qPCR) on DBS. 
Malaria RDT had a higher positivity rate (6.5%) 
than qPCR (4.2%) or microscopy (2.9–2.5%) with 
poor correlation between RDT and microscopy re-
sults. Overall, agreement among the three diag-
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nostic approaches was limited and neither micros-
copy nor qPCR were suitable for RDT quality moni-
toring under field conditions (65). McMorrow et al. 
noted that quality monitoring of RDTs using poor 
quality blood films might undermine confidence 
in RDT use (66). Blood samples for malaria antigens 
for RDT PT must be stored at 4 °C for a maximum 
of 48 hours, or for longer at –70 °C (67). Methods 
for preparing stable positive controls from cul-
tured P. falciparum using DBS and dried tube spec-
imens (DTS) have been demonstrated (68,69). 
Tamiru et al. reported performance of DTS PT chal-
lenges at 1000 and 500 parasites/µL in a field trial 
in Ethiopia; false negative DTS at 500 parasites/μL 
were reported after 24 weeks’ storage due to er-
rors in interpreting faint test lines (70). Aggett re-
ported stability of CD4 PT samples as only 7 days 
at ambient temperature and 14 days when refrig-
erated (32). There are no internationally agreed 
EQA methods for blinded rechecking of fluores-
cent TB smears (71).  
Studies have highlighted the difficulties in RL 
countries of transporting panels to peripheral sites 
and returning results, or submitting samples for 
rechecking to reference laboratories. Mukadi et al. 
used a combination of on-site delivery by car and 
private air carrier to provincial airports in DRC (38) 
with responses using short messaging services 
(SMS) (17). The NICD, South Africa, scheme used 
express air courier (31). Motorcycles were used to 
support EQA of malaria microscopy in Pakistan 
(54). There are obvious logistical advantages to us-
ing district-level laboratories to conduct recheck-
ing with reduced distances and costs, and ease of 
feedback to laboratories (58).
Costs
Published information on costs of operating EQA 
programmes in RL settings is limited. Khan et al. 
reported a capital cost of approximately 90,000 
Pakistani rupees (USD 1400) to implement a dis-
trict malaria-microscopy EQA scheme, including 
motorcycles and training of district laboratory su-
pervisors. This amounted to a 50% increase in di-
rect per-slide cost, but Khan argued this is margin-
al to the high capital and recurrent costs of micros-
copy services, and its value in rationalising anti-
malarial drug use (54). Mukadi et al. reported the 
cost of conducting one PT survey in DRC was USD 
10,000 excluding salaries (USD 25 per participant) 
(38).
Discussion
Countries with developing healthcare systems 
mostly lie in tropical areas where common diseas-
es, such as malaria and diarrhoeal diseases, require 
immediate diagnosis (within a few hours). Coupled 
with poor communication across large distances, 
this necessitates placing laboratory testing close 
to where patients seek care, resulting in large 
numbers of small laboratories working indepen-
dently. Most small laboratories still perform mainly 
manual assays, which are particularly prone to er-
rors during sample collection, labelling and regis-
tration; and many laboratory staff at this level lack 
skills in recognising pathology, and transcribing 
and delivering results. Combined, these errors can 
lead to significant variance in the accuracy of re-
sults, leading to incorrect diagnosis, inappropriate 
treatment or withholding of lifesaving therapy 
(22). Lack of adequate resources to support these 
laboratory networks has resulted in equipment 
breakdowns, interruption of supplies and variable 
performance. For many laboratories across RL 
countries, the quality of services is unknown.
Participation in EQA is ideally required for all test-
ing procedures performed in a laboratory. Where 
an established PT scheme is not available, alter-
nate EQA mechanisms should be considered. All 
EQA approaches depend for their effectiveness on 
following national or regional protocols, good 
communication and feedback, and instituting cor-
rective measures. The benefits of EQA schemes 
rest on mandatory participation, timely return of 
results with practical suggestions for corrective ac-
tion and ability of participating laboratories to ad-
dress deficiencies. Nothing is gained from EQA 
participation unless information received is direct-
ed to laboratory improvement (23).
PT programmes may be organised at national, re-
gional and international levels and funded 
through government agencies, as arms of corpo-
rations, or operated on a cost-recovery basis. Most 
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government-supported schemes in RL countries 
address single diseases using a vertical approach, 
such as malaria, TB and HIV infection; developed 
country and commercial schemes address a range 
of laboratory disciplines. Some PT schemes focus 
on different laboratory system levels, such as the 
NICD scheme (national public health laboratories) 
and EA-REQAS (primary level laboratories). Com-
mercial PT providers and developed country PT 
schemes are accredited to ISO 17043:2010 stand-
ards, but few PT schemes in RL countries are ISO 
compliant.
Rechecking schemes are commonly incorporated 
into national disease control programmes. WHO 
recommends integrating malaria microscopy re-
checking with other microscopically diagnosed 
communicable diseases, which is feasible with 
proper coordination at peripheral and national 
levels (52,56). Rechecking schemes require labora-
tories to follow correct procedures to avoid slide 
selection bias. Laboratory workers may retain 
slides of good quality and staining regardless of 
instructions; some laboratories may not submit 
slides for rechecking due to lack of confidence in 
their performance or uncertainty about implica-
tions of unsatisfactory performance (47,49). Few 
reports indicated the competency of staff con-
ducting the rechecking process but relied on con-
cordance of slide reading to determine accuracy; 
this can be addressed by including reference cen-
tre rechecking that assesses both peripheral labo-
ratory technicians and their immediate supervi-
sors; and conducting regular competency assess-
ments of slide readers. Various standards have 
been proposed to assess competency in TB slide 
reading but only malaria microscopy has an estab-
lished globally recognised competency assess-
ment programme (52,59,60). Regular competency 
assessment of supervisors and reference-level 
staff urgently needs to be incorporated into na-
tional EQA programmes. 
A process of rechecking can also be applied to 
rapid testing assays, such as RDT for HIV, where an 
alternative technique, such as enzyme immunoas-
say (EIA) or ELISA is used on dried blood or serum 
spot samples (57). Rechecking of samples by peer 
or higher level laboratories (inter-laboratory com-
parison) is appropriate for specialised tests for 
which no PT schemes exist, or for single unusual 
results; however, no published studies were identi-
fied demonstrating use or benefits of inter-labora-
tory comparisons in RL countries. On-site visits to 
laboratories by qualified auditors using standard 
checklists also provide a reliable EQA mechanism 
by implementing practical improvements to ad-
dress identified gaps. 
PT schemes are limited by the availability of stable 
PT materials that can withstand conditions of heat 
and humidity often found in RL countries, but 
have the unique advantage of being able to ad-
dress uncommon pathology for which staff need 
to retain competence. However, PT samples are 
constrained by being unable to provide challeng-
es that mimic some patient samples, such as living 
organisms and cells (72). PT panels may be placed 
within a clinical context and involve other health 
worker cadres in responses (73,74). Although all 
EQA programmes can provide inter-laboratory 
comparisons (benchmarking) when adequate data 
management systems are in place, this aspect is 
particularly suited to PT programmes where data 
are collected and analysed centrally. PT schemes 
use either referee laboratories or consolidated re-
sults from participants to set target values; in RL 
countries use of participant results may lead to 
lowering of precision when new participants join a 
scheme, but precision is usually restored once par-
ticipants become more experienced (33).
Although every laboratory should treat PT sam-
ples as routine samples, this is impossible to moni-
tor and enforce. Most laboratories in RL settings 
pay special attention to PT samples, especially pa-
thology recognition by microscopy. Therefore, PT 
results are likely to be the very best that a labora-
tory can produce; poor results may reflect a worse 
performance under routine conditions. Participa-
tion in PT schemes should not be punitive, but re-
garded as an educational tool to objectively assess 
laboratory performance and direct improvement 
efforts. Regular participation is the first step to us-
ing PT as an effective tool for laboratory improve-
ment and benefits will accrue if laboratories re-
view results and possible causes of errors, re-ex-
amine samples, keep records of performance and 
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use schemes as group learning exercises. Keeping 
health facility managers and authorities informed 
of reasons for poor performance provides the jus-
tification for allocating resources to maintain qual-
ity. At central level, PT schemes can provide ongo-
ing post-market surveillance of commercial test 
kits, quantify errors associated with a particular 
technology, identify the best technologies to use, 
identify training needs and indicate the need for 
governments to validate and standardise equip-
ment and methodologies (33). 
Many published reports present unacceptable lab-
oratory performance in EQA in RL countries, indi-
cating the vital importance of ongoing monitoring 
and corrective actions. Implementation of correc-
tive actions is primarily the responsibility of labo-
ratory personnel and management and is depend-
ent on established hierarchical supervisory struc-
tures. Supervisors making on-site visits can assess 
pre- and post-analytical aspects of laboratory pro-
cedures, and address technical performance 
through mentorship and ensuring functional 
equipment and adequate supplies; only a field vis-
it can convey a realistic picture of the conditions 
under which technicians work (63). Supervisory 
visits are more effective when standard checklists 
are used systematically (75). Visits by effective su-
pervisors are highly motivating for laboratory 
workers, but are time-consuming and expensive 
when considered across thousands of small labo-
ratories; regular visits may not be sustained unless 
linked with PT performance to target poorly per-
forming laboratories. Some PT schemes offer assis-
tance with training and corrective action or link 
with entities that provide this support (31,33). 
Novel applications using mobile technology may 
enhance the reach and benefits of EQA pro-
grammes in RL countries. Mobile camera phones 
can capture and transmit images directly from the 
eyepiece of an ordinary laboratory microscope to 
a central review site for feedback (76-78). The rapid 
expansion of mobile networks and internet cover-
age, and decreasing operational costs, offer op-
portunities to develop PT programmes that pro-
vide images of rare pathology or pathology that 
cannot be mass produced, such as histology speci-
mens or organisms found in spleen or bone mar-
row. Several PT providers in developed countries 
are already implementing this approach. 
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